RXRX R&D to Revenue
Recursion Pharmaceuticals Inc Clas · R&D to Revenue
RXRX R&D to Revenue
Latest reported1168.37%period ending
RXRX Quarterly R&D/Revenue (0.00% → 1168.37%)
Latest values, visible window
High-resolution chart · PNG
RXRX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,168.3703% | |
| 1,358.0964% | |
| 234.5067% | |
| 2,339.3623% | |
| 673.3811% | |
| 879.1726% | |
| 2,179.8714% | |
| 286.021% | |
| 513.2463% | |
| 500.7783% | |
| 654.0098% | |
| 693.0014% | |
| 499.8184% | |
| 384.6794% | |
| 321.5853% | |
| 312.8476% | |
| 502.2736% | |
| 612.2099% | |
| 1,931.68% | |
| 1,329.84% | |
| 1,184.96% | |
| 964.36% | |
| 811.3681% | |
| 1,918.2135% | |
| 0% | |
| 0% |